Ryali becomes CFO of Codexis
Plus: Levisetti made CMO at Cue, and updates from Qu and Biocrucible
Enzyme engineering company Codexis Inc. (NASDAQ:CDXS) hired Sri Ryali as CFO. Ryali was CFO at Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR), and before that, VP of finance at Aimmune Therapeutics Inc.
Cue Biopharma Inc. (NASDAQ:CUE) promoted SVP of Clinical Development Matteo Levisetti to CMO, succeeding acting CMO Kenneth Pienta, who will become a clinical adviser to the company. Levisetti was CMO at DNAtrix Inc. before joining Cue, which is developing biologics to activate T cells using its Immuno-STAT platform, in 2021...